Sign In
Buy IDXX
$560.73
+9.91 (+1.80%)
At Close: Jun 03, 2026
IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise
10:46am, Monday, 02'nd Feb 2026
IDXX tops Q4 EPS and revenue estimates as margins expand. However, shares dip during the pre-market trading, while 2026 guidance calls for steady growth.
Idexx (IDXX) Reports Q4 Earnings: What Key Metrics Have to Say
10:31am, Monday, 02'nd Feb 2026
While the top- and bottom-line numbers for Idexx (IDXX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare
Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates
08:41am, Monday, 02'nd Feb 2026
Idexx Laboratories (IDXX) came out with quarterly earnings of $3.08 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.62 per share a year ago.
IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics
08:12am, Monday, 02'nd Feb 2026
Animal diagnostics maker IDEXX Laboratories on Monday forecast 2026 revenue and profit above Wall Street estimates, betting that resilient demand at veterinary clinics and higher testing per visit wil
First Look: Gold Slumps, Disney (DIS) Beats, Oracle (ORCL) Plans $50B
07:37am, Monday, 02'nd Feb 2026
Stock News Gold and silver extend sharp sell-off: Spot gold and silver tumbled after Friday's historic plunge, pressured by a stronger dollar, profit-taking, an
Breakfast News: Metals Meltdown Mauls Markets
07:30am, Monday, 02'nd Feb 2026
Futures hit by gold and silver dip, Disney releases first-quarter earnings, and more
IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results
06:30am, Monday, 02'nd Feb 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. Fourth Quarter and Full
Mediolanum International Funds Ltd Raises Holdings in IDEXX Laboratories, Inc. $IDXX
05:24am, Sunday, 01'st Feb 2026
Mediolanum International Funds Ltd lifted its stake in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 14.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange C
AE Wealth Management LLC Sells 4,526 Shares of IDEXX Laboratories, Inc. $IDXX
04:42am, Sunday, 01'st Feb 2026
AE Wealth Management LLC trimmed its stake in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 39.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exch
IDEXX Laboratories, Inc. $IDXX Shares Sold by Truist Financial Corp
04:42am, Sunday, 01'st Feb 2026
Truist Financial Corp reduced its stake in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 14.6% during the undefined quarter, according to its most recent Form 13F filing with the Securities and
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
01:45pm, Thursday, 29'th Jan 2026
Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
Federated Hermes Inc. Increases Stock Position in IDEXX Laboratories, Inc. $IDXX
04:26am, Thursday, 29'th Jan 2026
Federated Hermes Inc. lifted its position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 269.7% during the third quarter, according to its most recent disclosure with the Securities and Excha
Curious about Idexx (IDXX) Q4 Performance? Explore Wall Street Estimates for Key Metrics
10:16am, Wednesday, 28'th Jan 2026
Get a deeper insight into the potential performance of Idexx (IDXX) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some
Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings
08:45am, Wednesday, 28'th Jan 2026
Ahead of Q4 earnings, IDXX eyes double-digit revenue and EPS growth, driven by CAG momentum, new diagnostics and steady Water gains.
IDEXX Laboratories, Inc. $IDXX Shares Bought by Bank of New York Mellon Corp
05:22am, Wednesday, 28'th Jan 2026
Bank of New York Mellon Corp lifted its stake in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 41.7% in the third quarter, according to its most recent Form 13F filing with the Securities and E
